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OBJECTIVE— The purpose of this study was to characterize differences in the acute insulin
response to glucose (AIRg) relative to insulin sensitivity (SI) in black and white premenopausal
normoglycemic South African women matched for body fatness.
RESEARCH DESIGN ANDMETHODS— Cross-sectional analysis including 57 black
and white South African women matched for BMI, SI, AIRg, and the disposition index (AIRg 
SI) were performed using a frequently sampled intravenous glucose tolerance test with
minimal model analysis, and similar measures were analyzed using an oral glucose tolerance
test (OGTT). Body composition was assessed by dual-energy X-ray absorptiometry and
computed tomography.
RESULTS— SI was significantly lower (4.4 0.8 vs. 9.4 0.8 and 2.9 0.8 vs. 6.0 0. 8
105 min1/[pmol/l], P 0.001) and AIRg was significantly higher (1,028 255 vs. 352 246
and 1,968 229 vs. 469 246 pmol/l, P 0.001), despite similar body fatness (30.9 1.4 vs.
29.7  1.3 and 46.8  1.2 vs. 44.4  1.3%) in the normal-weight and obese black women
compared with their white counterparts, respectively. Disposition index, a marker of -cell
function, was not different between ethnic groups (3,811 538 vs. 2,966 518 and 3,646
485 vs. 2,353  518  105 min, P  0.10). Similar results were obtained for the OGTT-
derived measures.
CONCLUSIONS— Black South African women are more insulin resistant than their white
counterparts but compensate by increasing their insulin response to maintain normal glucose
levels, suggesting an appropriate -cell response for the level of insulin sensitivity.
Diabetes Care 32:860–865, 2009
T ype 2 diabetes is a significant con-tributor to morbidity and mortalityworldwide and was ranked as the
seventh leading cause of death among in-
dividuals of all ages in South Africa in
2000 (1). The relatively high prevalence
of diabetes has been accompanied by a
high prevalence of obesity in South-
African women (2), as 87% of all type 2
diabetes in South Africa has been attrib-
uted to excess body weight (3).
For reasons that have not yet been ex-
plained, both black South African and Af-
rican American women are more insulin
resistant than their adiposity-matched
Caucasian counterparts (4–8). Insulin re-
sistance in African Americans has been as-
sociated with hyperinsulinemia (6 – 8),
due in part to reduced hepatic insulin ex-
traction (7,8). In contrast, insulin resis-
tance in black South African women has
been associated with insulinopenia
(5,9,10). However, the women in the pre-
vious studies were either not matched for
glucose tolerance (5,10) or glucose toler-
ance and insulin sensitivity were not mea-
sured (9), making interpretation of -cell
function difficult. Thus, it is an open
question whether -cell function, as-
sessed using state-of-the-art methods, dif-
fers in normoglycemic South African
women of different ethnicities who are
otherwise well matched.
It has become clear that insulin sensi-
tivity is an important modulator of the
-cell response (11). The relationship be-
tween insulin sensitivity and insulin re-
sponse is hyperbolic in nature, such that
as insulin sensitivity decreases, normal
-cells will increase their insulin response
to maintain normoglycemia. This hyper-
bolic relationship allows for the product
of insulin sensitivity and insulin response
to be calculated, with the resultant pa-
rameter being termed the disposition in-
dex. The disposition index is highly
heritable and correlates strongly with glu-
cose tolerance such that individuals with
the lowest disposition index are at in-
creased risk for or already have type 2
diabetes (12).
By estimating the disposition index,
we aimed to better define -cell function
in black and white South African women
matched for body fatness. Further, we
aimed to compare these measures with
estimates of glucose metabolism obtained
using an oral glucose tolerance test
(OGTT).
RESEARCH DESIGN AND
METHODS— The study sample con-
sisted of 13 normal-weight (BMI 18–25
kg/m2) black, 14 normal-weight white,
16 obese (BMI30 kg/m2) black, and 14
obese white South African women, who
were recruited by advertisement in local
news articles and from local church
groups, community centers, and univer-
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sities. Additional inclusion criteria were
1) age 18–45 years, 2) no known diseases
and not taking medication for diabetes,
hypertension, HIV infection/AIDS, or any
other metabolic disease, 3) not currently
pregnant, lactating, or postmenopausal,
and 4) of South African ancestry. The
study was undertaken in accordance with
the guidelines of the Declaration of Hel-
sinki and was approved by the Research
Ethics Committee of the Faculty of Health
Sciences of the University of Cape Town.
Before participating in the study, proce-
dures and risks were explained to the sub-
jects, all of whom gave written informed
consent to participate in the study.
Testing procedures
Body composition assessment. Basic
anthropometric measurements, including
weight, height, and waist (at the level of
the umbilicus) and hip (largest gluteal
area) circumferences were taken. Body fat
was measured using dual-energy X-ray
absorptiometry (Discovery-W, software
version 4.40; Hologic, Bedford, MA).
Body composition of subjects that ex-
ceeded the scanning region (n  15
[26%]) was calculated using the arm-
replaced method (13). The coefficients of
variation for measurements of fat-free tis-
sue mass and fat mass were 0.7 and 1.7%,
respectively. Abdominal visceral and sub-
cutaneous adipose tissue areas were mea-
sured using computed tomography
(Xpress helical scanner; Toshiba, Tokyo,
Japan) at the level of L4 –L5 lumbar
vertebrae.
Blood sampling and measurement of
glucose tolerance, insulin sensitivity,
and insulin release. Subjects completed
an insulin-modified frequently sampled
intravenous glucose tolerance test
(FSIGT). After an overnight fast, cannulae
were inserted into the antecubital vein of
each arm. One arm was used for intrave-
nous glucose and insulin infusions and
the contralateral arm was used for blood
sampling. The arm used for blood sam-
pling was heated to arterialize venous
blood. Baseline samples were taken at
15, 5, and 1 min before a bolus of
glucose (50% dextrose; 11.4 g/m2 body
surface area) was infused intravenously
over 60 s beginning at time 0 min. At 20
min, human insulin (0.02 unit/kg, Ac-
trapid; Novo Nordisk) was infused over 5
min at a constant rate. Samples for deter-
mination of plasma glucose and serum in-
sulin concentrations were drawn at 2, 3,
4, 5, 6, 8, 10, 12, 14, 16, 19, 22, 23, 24,
25, 27, 30, 35, 40, 50, 60, 70, 80, 90,
100, 120, 140, 160, 180, 200, 220, and
240 min. This sampling schedule allows
for the identification of parameters using
the minimal model of glucose kinetics
(14) and the acute insulin response to glu-
cose (AIRg). The samples were centrifuged
at 3,000 rpm for 10 min at 4°C, the plasma
was stored at20°C for subsequent analy-
sis of glucose concentrations, and the serum
was stored at 80°C for the subsequent
analysis of insulin concentrations.
On a separate day, a fasting venous
blood sample was drawn for the determi-
nation of plasma glucose and serum insu-
lin levels. Subjects then underwent a 75-g
OGTT, during which blood was drawn at
30-min intervals for 2 h for the measure-
ment of plasma glucose and serum insulin
concentrations.
Biochemical analysis
Plasma glucose concentrations were de-
termined using the glucose oxidase
method (YSI 2300 STAT Plus; YSI, Yellow
Springs, OH). Serum insulin concentra-
tions were determined by immunochemi-
luminometric assays using the ADVIA
Centaur (Bayer Diagnostics). The intra-
assay and interassay coefficients of varia-
tion for plasma glucose and serum insulin
concentrations were 0.6 and 2.5 and 4.5
and 12.2%, respectively.
Calculations
Glucose and insulin data from the FSIGT
were used to calculate indexes of insulin
sensitivity (SI) and glucose effectiveness
(Sg) (the ability of glucose to promote its
own uptake at basal insulin levels) using
Bergman’s minimal model of glucose ki-
netics (14). AIRg was calculated as the
mean incremental insulin response above
basal between 2 and 10 min after the in-
travenous glucose bolus was started.
-Cell function was determined as the
disposition index, which was calculated
as the product of SI and AIRg (11). The
glucose disappearance constant (Kg), a
measure of intravenous glucose tolerance,
was calculated as the slope of the natural
log of glucose from 10 to 19 min, ex-
pressed as percent change per minute.
The early insulin response during the
OGTT, also known as the insulinogenic
index, was calculated as the ratio of the
change in insulin to the change in glucose
from 0 to 30 min ( insulin0 –30/
glucose0–30). The oral disposition index
(DIo), a measure of -cell function de-
rived from the OGTT, was calculated as
insulin0 –30/glucose0 –30  1/fasting
insulin (15). Three subjects (one normal-
weight and two obese black women) had
a negative insulin(0–30)/glucose(0–30)
measurement and were excluded from
analyses including this parameter.
Statistics
Results are presented as means  SEM.
Two-way ANCOVA, adjusting for age,
was used to compare anthropometric and
metabolic measures between normal-
weight and obese women of different eth-
nicity, with Bonferroni post hoc analyses.
Repeated-measures ANOVA with Tukey
post hoc analyses was used to explore dif-
ferences in the glucose and insulin re-
sponses during the OGTT over time. Data
were normalized by log transformation
for statistical analyses when required.
Data were analyzed using STATISTICA
(version 7; StatSoft, Tulsa, OK). P 0.05
was considered significant.
RESULTS
Subject characteristics
On average, the obese women were sig-
nificantly older than the normal-weight
women (P  0.002) (Table 1). Conse-
quently, all subsequent analyses were co-
varied for age. By design, all measures of
body composition and regional fat depo-
sition were significantly greater in the
obese than in the normal-weight women
(Table 1). There was a difference in stat-
ure between the black and white women
(Table 1), with the black women being on
average 10 cm shorter than the white
women (P 0.001) and weighing signif-
icantly less (P  0.039). However, the
black and white groups were well
matched for BMI and body fat. Although
there were no ethnic differences in waist
circumference and waist-to-hip ratio,
obese black women had less visceral adi-
pose tissue (P  0.006) but more subcu-
taneous adipose tissue (P  0.013) than
obese white women.
Glucose tolerance, insulin
sensitivity, and insulin response to
glucose
The glucose profile during the FSIGT was
similar in black and white women,
whereas the insulin profile after glucose
injection was greater in black women
(Fig. 1). SI was significantly lower and
AIRg was significantly higher in black
women than in white women (Table 2)
and in obese women than in normal-
weight women in both ethnic groups (P
0.001). Ethnic differences in SI and AIRg
persisted after adjustment for differences
Goedecke and Associates
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in visceral adipose tissue and subcutane-
ous adipose tissue areas. Disposition in-
dex (SI  AIRg) was not significantly
different between ethnic and BMI groups,
as was also the case for Sg. However, obese
black women had better Kg than obese
white women (P  0.044).
Glucose and insulin levels in response
to the oral glucose challenge are pre-
sented in Table 2 and Fig. 2. All subjects
had normal glucose tolerance by Ameri-
can Diabetes Association criteria. Two-
hour plasma glucose levels were
significantly higher in normal-weight
black than in normal-weight white
women (5.0  0.3 vs. 3.8  0.3 mmol/l,
P  0.016), with no differences between
the obese black and white women (5.7
0.2 vs. 4.8  2.3 mmol/l, P  0.132).
Fasting serum insulin levels were greater
in black women than in white women
(P 0.001) and in obese women than in
normal-weight women (P  0.001). The
insulinogenic index [insulin(0 –30)/
glucose(0–30)] was significantly higher
in both normal-weight and obese black
women than in their white counterparts
(Table 2). With adjustment for the effect
of insulin sensitivity to modulate the in-
sulin response, DIo [insulin(0 –30)/
glucose(0–30)  1/fasting insulin] was
not different between the BMI and ethnic
groups.
CONCLUSIONS— In the present
study, we assessed for the first time in a
sample of normoglycemic black and
white South African women matched for
BMI the relationship between insulin sen-
sitivity and insulin response, which de-
scribes the ability of the -cells to
compensate for insulin resistance (11).
We found that insulin resistance in the
black women was associated with an ap-
propriately greater insulin response to
maintain normoglycemia compared with
that in their white counterparts. Thus, the
disposition index, which measures -cell
function, did not differ in black and white
South African women.
The findings of this study, therefore,
do not support the concept that insulin
Table 1—Subject characteristics
Normal-weight
black
Normal-weight
white Obese black Obese white
n 13 14 16 14
Age (years) 24  2 26  2 28  1 31  2
Height (cm) 158.8  1.8* 169.6  1.8* 157.1  1.6† 167.2  1.8†
Weight (kg) 59.2  3.1* 64.8  3.0† 94.1  2.9* 98.8  2.8†
BMI (kg/m2) 23.4  1.0* 22.6  0.9† 38.0  0.9* 35.2  0.9†
Body fat (%) 30.9  1.4* 29.7  1.3† 46.8  1.2* 44.4  1.3†
Waist circumference (cm) 76.7  2.8* 80.1  2.8† 113.6  2.6* 105.7  2.8†
WHR 0.77  0.02* 0.78  0.02† 0.90  0.02* 0.85  0.02†
VAT (cm2) 60.4  11.5* 59.9  10.7† 101.5  11.1*‡ 143.8  11.1†‡
Total SAT (cm2) 176.7  22.3* 175.5  20.7† 591.3  21.4*‡ 492.2  21.4†‡
Values are unadjusted means SEM. All P values were adjusted for age. *,†,‡Matching superscript symbols
represent groups that are significantly different from each other, P 0.01. SAT, subcutaneous adipose tissue;
VAT, visceral adipose tissue; WHR, waist-to-hip ratio.
Figure 1—Plasma glucose and serum insulin responses during an FSIGT in normal-weight (A) and obese (B) black (F) and white (E) women.
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resistance in nondiabetic black South-
African women is associated with insuli-
nopenia, previously attributed to a
reduction in -cell mass (16). Rather, the
results of this study correspond to those
reported in African Americans, in whom
insulin resistance is associated with hy-
perinsulinemia (6–8). The higher AIRg in
African Americans has been attributed to
both greater insulin secretion and re-
duced hepatic insulin extraction (8). In
fact, the greater peak insulin level in the
black women after insulin injection at 20
min during the FSIGT, occurring despite
the fact that they weighed less and there-
fore received less insulin than the white
women (Fig. 1), is also in keeping with
black South African women having re-
duced insulin clearance.
The previous studies in which insulin
resistance in black South African women
was associated with insulinopenia mea-
sured insulin and C-peptide levels in the
fasted state and in response to an OGTT
and found them to be lower in black than
in white women (4,5,10). However, the
women in these studies were not matched
for glucose tolerance. For example, in two
separately published studies, 2-h post-
OGTT glucose levels were 	4.5 mmol/l
in white women but as high as 	7.5
mmol/l in the age- and BMI-matched
black women (5,10). Thus, the relative
degree of insulinopenia in the black
women may be related to reduced glucose
tolerance, which is known to be associ-
ated with impaired -cell function (17).
Other reports supporting the premise of
insulinopenia in the black South African
population either did not measure glu-
cose tolerance or insulin sensitivity (9),
made no direct comparisons with white
subjects (16,18), or compared individu-
als with frank diabetes (19). More recent
studies have shown no differences in the
insulin response to an oral glucose load
between well-matched black and white
women (20,21). In fact, a greater 30-min
insulin response to a mixed meal (22) and
higher fasting C-peptide levels (23) have
recently been reported in South African
black compared with white women
matched for BMI and glucose tolerance.
The findings of our study showing a
greater insulinogenic index in black com-
pared with white women are thus com-
patible with these more recent reports.
Disposition index has been shown to
decrease with increasing fasting glucose
levels, even in subjects considered to be
normoglycemic (17), and can be used to
identify individuals at increased risk for
type 2 diabetes (12). However, intrave-
nous glucose tolerance testing is expen-
sive and time consuming, reducing its use
in resource-limited countries such as
South Africa. Alternatively, the DIo can be
calculated from the hyperbolic relation-
ship between the early insulin response
and insulin sensitivity during a standard
OGTT (15). Although less precise than
FSIGT-derived measures, DIo has been
Table 2—Glucose tolerance, insulin sensitivity, and release
Normal-weight
black
Normal-weight
white Obese black Obese white
n 13 14 16 14
FSIGT
SI ( 10
5 min1/
pmol/l) 4.4  0.8* 9.4  0.8* 2.9  0.8§ 6.0  0.8§
AIRg (pmol/l) 171.3  42.5** 58.6  41.0** 328.0  38.2§ 78.2  41.0§
Disposition index ( 105 min1) 3,811  538 2,966  518 3,646  485 2,353  518
Sg ( 10
1 min) 0.25  0.03 0.24  0.02 0.28  0.02 0.24  0.02
Kg (%/min) 2.81  0.35 2.44  0.34 3.46  0.31* 2.22  0.34*
OGTT
Fasting glucose (mmol/l) 4.5  0.1 4.4  0.1 4.6  0.1 4.7  0.1
Fasting insulin (pmol/l) 59.0  8.0* 28.5  7.7*§ 90.6  7.2‡ 52.5  7.7§‡
insulin(0–30)/glucose(0–30) 437  70* 184  65* 507  65† 248  65†
DIo (mmol/l) 7.7  1.3 7.6  1.2 5.1  1.2 5.0  1.2
Values are unadjusted means SEM. All P values were adjusted for age. *,†,‡,§Matching superscript symbols represent groups that are significantly different from
each other, P  0.05; **P  0.01.
Figure 2—Plasma glucose and serum insulin responses to a 75-g oral glucose load in normal-weight (Œ,‚) and obese (F,E) black (Œ,F) andwhite
(‚, E) women. *P  0.05 for black versus white normal weight; #P  0.05 for black versus white obese.
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shown to be predictive of the develop-
ment of diabetes over 10 years, even be-
yond that of fasting or 2-h post-OGTT
glucose levels (15). The data from the cur-
rent study, in which the insulinogenic in-
dex was higher and insulin sensitivity was
lower in black than in white women, sug-
gest that the degree of -cell compensa-
tion in our sample of black women was
appropriate, as DIo was not different
based on ethnicity.
Based on the finding of similar dispo-
sition index values in the black and white
women in this study, one would assume a
similar risk for type 2 diabetes in these
two population groups. However, the
prevalence of type 2 diabetes in South Af-
rica is higher in the black population than
in the white population (24). A similar
scenario is presented in African Ameri-
cans, who have a higher prevalence of
type 2 diabetes but display a similar or
higher disposition index than their Cau-
casian counterparts (6,7). The mecha-
nisms underlying the increased risk of
type 2 diabetes in black populations from
South Africa and the U.S. is not known.
Joffe et al. (16) proposed a scheme for the
pathogenesis of type 2 diabetes in the
black population of Southern Africa, in
which a reduction of -cell mass (due to
childhood malnutrition and/or genetic
factors), followed by an accelerated phase
of -cell decompensation induced by a
variable period of peripheral insulin resis-
tance, would ultimately lead to insuli-
nopenic type 2 diabetes. However, to our
knowledge, there is no evidence of a re-
duction in-cell mass in the general black
population. In fact, exaggerated glucose-
stimulated insulin secretion appears to be
a characteristic of individuals with normal
glucose tolerance who are at risk for type
2 diabetes (Pima Indians and African
Americans) (25).
A limitation of our study is that the
subjects were not randomly drawn from
the population but comprised volunteers
who had responded to a recruitment ad-
vertisement. Thus, there is the possibility
that they may not be representative of the
population at large. However, our finding
of insulin resistance in black women is in
keeping with previous observations re-
ported from South Africa (4,5). The rea-
sons for the differences in insulin
sensitivity and insulin responses and
whether they apply to the general popu-
lation are unclear. Aside from genetic dif-
ferences, environmental and lifestyle
differences exist between the black and
white South African populations, and it is
quite possible that these may have an im-
pact on measures associated with glucose
metabolism. For example, we found that
black South African women had lower so-
cioeconomic status, consumed more di-
etary fat, and had more subcutaneous and
less visceral fat than their white counter-
parts and that these factors explained in
part some of the differences in insulin
sensitivity ( J. H. Goedecke, unpublished
observations). However, even after ad-
justment for differences in fat distribu-
tion, the ethnic differences in SI and AIRg
were not obviated. Identification of other
factors and the mechanisms by which
they may be operating to affect glucose
metabolism is clearly needed. In addition,
longitudinal studies are required to deter-
mine whether the -cell will continue to
compensate in the black women with in-
creasing age or whether it will fail over
time, leading to disturbances in glucose
tolerance.
In summary, we have demonstrated
that black South African women are more
insulin resistant than their white counter-
parts but compensate by increasing their
insulin response to maintain normal glu-
cose levels. These findings refute previous
suggestions that insulin resistance in
black South African women is associated
with relative insulinopenia but rather sug-
gest an appropriate-cell response for the
level of insulin sensitivity. Future studies
are required to explore the mechanisms
underlying the high degree of insulin re-
sistance in apparently healthy black pop-
ulations and to establish whether their
hyperinsulinemic response to insulin re-
sistance is in fact associated with in-
creased or decreased risk of diabetes with
increasing age.
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